• Hey, guest user. Hope you're enjoying NeoGAF! Have you considered registering for an account? Come join us and add your take to the daily discourse.

Exclusive: Chinese scientists '99% confident' their coronavirus vaccine will work

longdi

Banned
Health 18:51, 19-May-2020
Chinese vaccines will be made global public good, says Xi
By Pan Zhaoyi

China will make its coronavirus vaccine a global public good once available, Chinese President Xi Jinping said on Monday.

In a speech to the 73rd session of the World Health Assembly (WHA) via video link at the invitation of the World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus, Xi pledged for greater international cooperation in the fight against the epidemic.

"COVID-19 vaccine development and deployment in China, when available, will be made a global public good, which will be China's contribution to ensuring vaccine accessibility and affordability in developing countries."

The announcement came amid growing concerns of countries putting national interests in front of the quest for life-saving vaccines. But Xi's remarks are considered to be strong responses to the worried voices, which also stroke a chord with EU's proposal noting the need for all countries to have "unhindered timely access" to vaccines, medicines, diagnostics and any other technologies for the deadly virus.

Xi's statement is "very significant" Hu Yuanqiong, senior legal and policy adviser for MSF Access Campaign which backs lower drug prices told Politico, a U.S-based media house. As both an R&D and manufacturing powerhouse, China needs "to be fully on board to deliver this collective global vision."

On a Monday press conference, Xu Qiang, head of the Beijing Municipal Science and Technology Commission told the media that three COVID-19 vaccines have entered phase II clinical trials in Beijing. Five candidates are already in human trials, according to the data released by the WHO.

During Xi's speech, he also promised that China will provide 2 billion U.S. dollars over two years to help with COVID-19 response and with economic and social development in affected countries, especially developing countries.

Two different statements from two top leaders

Xi's remark contradicts with what U.S. President Donald Trump said on late Monday, who threatened to permanently freeze funding to WHO and reconsider its country's membership.

"If the organization does not commit to major substantive improvements within the next 30 days, I will make my temporary freeze of the United States funding to the WHO permanent and reconsider our membership in the organization," Trump wrote in the letter.
 
after taking vaccine:
ed0.gif


2 days later:

tenor.gif


2 weeks later:
tumblr_p58mjzYVNS1wrjatso1_500.gifv


2 months later:
7xYa.gif
 

longdi

Banned
:messenger_bicep:

The biggest problem the company faces is the low number of COVID-19 cases in China, which makes testing the vaccine in an epidemic situation difficult. As a result, the company is looking further afield for stage 3 trials.

Helen Yang, senior director of investor relations, told Sky News: "We are speaking to several European countries and I think did discuss with the UK as well.

"Currently it's a very preliminary stage for the discussion."

The company is pressing ahead with production, though, even as it continues research.

In the company's headquarters in northwest Beijing, orange and white packets are already ready to go.

The aim of parallel tracks is that mass production of the vaccine can begin straight away, if the trials are successful and the vaccine gets regulatory approval.

It is currently building a commercial plant in another part of Beijing with the objective of delivering 100 million doses.

That number, large as it is, means limiting who gets the vaccine.

"It is our recommendation that it is not the whole population that gets the vaccine," Ms Yang told Sky News.

"We are discussing this and recommending it to other countries as well.

"We are firstly targeting high-risk groups, for example, health workers or senior citizens, who may have a higher level of fatality rate. I think that will be the starting point. To be frank, the vaccine needs to be produced lot by lot."

And the vaccine won't be here soon. The stage 2 trials have months to run before Stage 3 can begin, Ms Yang pointed out, and then the vaccine requires regulatory approval.

Asked whether she was sure of success, Ms Yang told Sky News: "It's very hard to say, very difficult to say at the moment. There are uncertainties, but the data: so far, so good."

There is a global race to come up with a COVID-19 vaccine - but questions remain about how it would be distributed, and whether countries should prioritise their own populations.

Drugmaker AstraZeneca, which is working with researchers at Oxford University, said the UK would be the first country to get access to the vaccine it is developing.

Chinese President Xi Jinping has pledged that any Chinese vaccine would be a "global public good", even though the practical results of that are unclear. EU leaders have made a similar commitment, but US President Donald Trump has not.

Ms Yang told Sky News: "We are already considering not only China but also the whole world, not only for conducting a trial but also how to supply a solution for countries including China and outside China."
 

longdi

Banned
I wonder if any way to buy Chinese pharma stocks now? :eek:

  • Just days after China’s annual parliamentary meeting wrapped up, the world is confronted with hints of what the international landscape will look like after the coronavirus.
  • In the face of a global recession, China looks set to be one of the few countries that will expand, economically and politically, analysts say.
  • “We don’t want to leave China,” said Joerg Wuttke, President of the European Chamber of Commerce in China. “That’s why we engage more with China and ask for more.”
Investments into China
China, where the coronavirus first emerged late last year in the city of Wuhan, is also the first country to recover from business shutdowns imposed in an effort to control the outbreak.

More than 4,600 people have died from Covid-19 in China, while the death toll tops 100,000 in the U.S., the hardest-hit country in the world. The virus that caused a global pandemic has infected well over 6 million people worldwide.
According to the latest International Monetary Fund projections, China is set to grow just over 1% in 2020, while the U.S. economy will likely contract nearly 6% this year — worse than the global 3% decline in growth.
“Globalization itself is going to survive. It’s going to be adjusted around some of these issues especially the tech,” said Walter Lohman, director of the Asian Studies Center at The Heritage Foundation, from which the Trump administration has drawn many of its staff.

“People are still going to want to invest in China for the China market,” he said in a phone call. “We’ve been talking about it for 100 years. It’s here now and there are companies that want to access it. China isn’t the worst place to do business. Even on the transparency side it’s kind of in the middle.”
For the first time in about two decades, the world’s second-largest economy did not to set an annual GDP target at its latest parliamentary meeting. Instead, authorities set targets for items such as unemployment. Many economists said removing the target will hopefully improve the quality of growth, and predict the economy could expand by about 1% to 3% this year.

Geopolitical tensions and the coronavirus have stalled foreign direct investment into China. But companies have vested interests that are unlikely to change quickly.
Analysts from research firm Gavekal Dragonomics said in a report in August that in 2016, American business sales in China topped $450 billion, while the Chinese sales in the U.S. were less than $50 billion.
“The signals in all of our communications and interactions with government is they are welcoming to American business in China, and really making it a point to ensure that whether it be related to subsidies or other types of support that they are supportive,” Alan Beebe, president of the American Chamber of Commerce in China, told reporters on Friday morning. “That’s been a pretty consistent trend that we’ve noticed this year.”
Beebe also noted the Chinese government has asked for the chamber’s support in recommending to policymakers effective ways that stimulus can be efficiently channeled to small- and medium-sized companies.


 

GAMETA

Banned
From the same country that once put out toxic baby formula, we should trust them to lead with a vaccine we'll inject into our bodies?

Well, to be honest, there's trillions to be made and we'll be seeing a gold rush to produce a proper vaccine.

I don't think China would want to fuck this up, so, for once, if it does get approved, their stuff should be good. Should.

I wouldn't want to be one of the guinea pigs, tho... I bet they'll be cutting corners in experimental stages.
 
I’m sure this would be fine since China wants to recover their image, and I am not anti-Chinese government... but I’m still gonna wait a bit before taking this. :):messenger_poop:
 

cryptoadam

Banned
Phase 2 trials can take a year and then they have to go to phase 3. Probably 2 or more years away.

Moderna also is starting phase 2 trials.
 

Chankoras

Member
Their p.r. machine working hard to create goodwill if I had to guess, mostly likely with rich in resources exploitable countries.
 
All of the Australian scientists that are working on the Vaccine are either sponsored by Chinese companies or have Chinese Scientists helping them
is that a Coincidence??

Tinfoil hat time
 

sobaka770

Banned
It's not really new: most countries have vaccine trials and we know that later stages and approvals will take months.
If Chinese get it earlier - good, but probably the other countries will quickly follow suit.
 

longdi

Banned
All of the Australian scientists that are working on the Vaccine are either sponsored by Chinese companies or have Chinese Scientists helping them
is that a Coincidence??

Tinfoil hat time

I think not just the Chinese, but every where around us, the rich and elites are making use of the virus to further enrich and enpower themselves!
 

-YFC-

Member
If I were to take a vaccine, I'd wait for the European/USA variant of it. No way I'm taking a chinese one.
 

longdi

Banned
China already dimissed Remdesivir, yet there was a moment of hype last month driving stock markets crazy
Then boom!
Capitalist!

Gilead Falls After Phase 3 Remdesivir 10-Day Trial Failed To Reach Significance
by Tyler Durden
Mon, 06/01/2020 - 08:45
TwitterFacebookRedditEmailPrint


One week after the New England Journal of Medicine found mixed results in its pivotal study of Remdesivir in covid-19 patients which "found no marked benefit from remdesivir for those who were healthier and didn’t need oxygen or those who were sicker, requiring a ventilator or a heart-lung bypass machine" and only "significantly helped those on supplemental oxygen", concluding that "given high mortality despite the use of remdesivir, it is clear that treatment with an antiviral drug alone is not likely to be sufficient", moments ago Gilead announced its own results from a Phase 3 trial of Remdesivir in patients with moderate Covid-19 and which, similarly, appeared to disappoint because while the press release was quick to point out that "patients in the 5-day remdesivir treatment group were 65% more likely to have clinical improvement at Day 11 compared with those in the standard of care group," this was not relevant, and what did matter is that "the odds of improvement in clinical status with the 10-day treatment course of remdesivir versus standard of care... failed to reach statistical significance."

The release scrambled to recover the Remdesivir momentum, quoting Francisco Marty, MD, an infectious diseases physician at Brigham and Women’s Hospital, and associate professor of medicine at Harvard Medical School, who said that "our understanding of the spectrum of SARS-CoV-2 infection severity and presentations of COVID-19 continues to evolve. These study results offer additional encouraging data for remdesivir, showing that if we can intervene earlier in the disease process with a 5-day treatment course, we can significantly improve clinical outcomes for these patients."
In short, anything to save the drug, even if the drug ultimately does not provide much of a benefit compared to placebo. In the end it will be up to the FDA to decide whether said lack of significance is enough to grant Gilead drug approval.
Key efficacy and safety results from the study are included in the table below.
 

DESTROYA

Member
Fuck that China can keep there vaccine Id rather take my chance riding this out for a alternative that actually works . It’s probably a delayed poison to kill the rest of us off.
FUCK CHINA
 
Top Bottom